首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Vaccine

Vaccine杂志,由Elsevier BV出版,于1983年创刊,Weekly,出版语言English,ISSN:0264-410X,E-ISSN:1358-8745。

投稿咨询
Vaccine
Vaccine
Vaccine
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
3.4
CiteScore
6.4
期刊收录
SCI、SCIE

Vaccine(中文译名:《疫苗》),ISSN:0264-410X,EISSN:1358-8745,是Elsevier BV出版的国际性学术期刊,创刊于1983年,以Weekly形式稳定发行,2026年总发文量约1124篇。该刊采用非OA开放访问,学科归属为医学 - 免疫学。该刊是医学、免疫学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.4,2025年期刊CiteScore为6.4,2025年期刊自引率约11.8%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Vaccine长期聚焦医学、免疫学及相关产业的技术应用前沿,平均审稿周期约4.5个月,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、免疫学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAEngland、CHINA MAINLAND、Australia、Switzerland、Canada、France等为核心发文国家与地区;CENTERS FOR DISEASE CONTROL & PREVENTION - USAWORLD HEALTH ORGANIZATION、UNIVERSITY OF LONDON、GLAXOSMITHKLINE、JOHNS HOPKINS UNIVERSITY、EMORY UNIVERSITY、PUBLIC HEALTH ENGLAND等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
IMMUNOLOGY 免疫学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
3区 3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
IMMUNOLOGY 免疫学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
3区 3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
IMMUNOLOGY 免疫学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
3区 3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q3 93 / 183

49.5

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 85 / 191

55.8

学科:IMMUNOLOGY SCIE Q2 64 / 183

65.3

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 62 / 191

67.8

2024-2025年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q2 81 / 183

56

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 68 / 195

65.4

学科:IMMUNOLOGY SCIE Q1 45 / 183

75.68

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 48 / 195

75.64


中国学者近期发文

1
Effectiveness of prescription-based influenza vaccination services among older adults in Binzhou, China: A cluster-randomized controlled tria

Author:Zhang, Lin; Lin, Tao; Wang, Mengjie; Ma, Xiaohui; Dong, Huijuan; Song, Jintong; Li, Yang

Journal: VACCINE. 2026; Vol. 82, Issue , pp. -. DOI: 10.1016/j.vaccine.2026.128588

2
Potential benefits of optimised varicella vaccination scenarios in a western Chinese province: a modelling study using real-world dat

Author:Zou, Zhuoru; Zhang, Haodan; Wang, Xinyu; Zhao, Ke; Hu, Weijun; Xia, Ruyi; Shen, Mingwang; Zhuang, Guihua

Journal: VACCINE. 2026; Vol. 81, Issue , pp. -. DOI: 10.1016/j.vaccine.2026.128587

3
The immune response of the mRNA vaccine CS-2034 as a heterologous booster before and after breakthrough infection: A follow-up stud

Author:Wu, Jun-Dong; Meng, Huan; Guo, Xi-Ling; Liu, Lei; Zhou, Guang-Hui; Liu, Wen-Qing; Qi, Xiao-Yuan; Li, Jing-Xin

Journal: VACCINE. 2026; Vol. 81, Issue , pp. -. DOI: 10.1016/j.vaccine.2026.128575

4
E-health literacy and herpes zoster vaccination intention: Health belief pathways and socioeconomic inequalitie

Author:Liu, Yujie; Wu, Birong; Wei, Mingbo; Gong, Ruijie; Liu, Shangbin; Xu, Chen; Ge, Xin; Tao, Shunyu; Hu, Fan; Wang, Ying; Xie, Juan; Cai, Yong

Journal: VACCINE. 2026; Vol. 80, Issue , pp. -. DOI: 10.1016/j.vaccine.2026.128502

5
An integrated health belief model and protection motivation theory approach to understanding herpes zoster vaccination intention among older adults in Chin

Author:Qu, Shujuan; Zhou, Min; Campy, Kathryn S.; Bu, Pingyuan

Journal: VACCINE. 2026; Vol. 80, Issue , pp. -. DOI: 10.1016/j.vaccine.2026.128508

6
Normalising enhanced influenza vaccines as a strategy to promote vaccination uptake in healthcare workers: Insights from a discrete choice experimen

Author:Chan, Chin Pok; Wong, Ngai Sze; Lee, Shui Shan

Journal: VACCINE. 2026; Vol. 80, Issue , pp. -. DOI: 10.1016/j.vaccine.2026.128539

7
Cost and effectiveness of COVID-19 vaccination strategies during the 2023 post-reopening omicron wave in Xinjiang, Western China: Evidence from SIR and Markov model

Author:Wu, Di; Liu, Kejun

Journal: VACCINE. 2026; Vol. 80, Issue , pp. -. DOI: 10.1016/j.vaccine.2026.128536

8
A Δssav deletion attenuates Salmonella Choleraesuis to generate a self-limiting, immunogenic vaccine candidat

Author:Pan, Hongyan; Zhao, Jing; Yang, Jing; Cao, Weisheng; Liu, Guangliang

Journal: VACCINE. 2026; Vol. 80, Issue , pp. -. DOI: 10.1016/j.vaccine.2026.128546

9
Immunogenicity and safety of a quadrivalent recombinant human papillomavirus vaccine (type 6/11/16/18) (Hansenula polymorpha): A randomized controlled phase 2 non-inferiority clinical tria

Author:Yang, Sensen; Dai, Defang; Kang, Zhuang; Zhang, Li; Du, Lifang; Kang, Yun; Chen, Shi; Jin, Yuqin; Hou, Junwei; Tang, Fang; Zhang, Xuefeng; Wang, Meiqiong; Liu, Zhicheng; Liu, Huan; Tan, Yao; Ma, Zhijing; Liu, Zhaoming; Zheng, Fan; Yuan, Jin; Cai, Feng; Zhao, Rongli; Xia, Wei; Zhang, Jing; Liang, Yu; Huang, Weijin; Li, Gang; Jiang, Zhiwei; Nie, Jianhui; Gao, Lidong; Qu, Ge; Li, Qiming

Journal: VACCINE. 2026; Vol. 80, Issue , pp. -. DOI: 10.1016/j.vaccine.2026.128527

10
Multi-mode spatial accessibility to vaccination services and its impact on influenza-related hospitalisations among older adult

Author:Zhang, Jiawei; Gong, Chao; Xu, Zhihu; Han, Runzhi; Qin, Yixin; Yang, Li; Liu, Yang

Journal: VACCINE. 2026; Vol. 80, Issue , pp. -. DOI: 10.1016/j.vaccine.2026.128540


在线咨询

Vaccine

国际简称:VACCINE参考译名:疫苗

年发文量:1124 CiteScore:6.4 是否预警:否 Gold OA文章占比:54.63% 研究类文章占比:91.01%

杂志社联系方式:ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND, OXON, OX5 1GB

Vaccine